Tufton Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-40,328
| Closed | -$1.34M | – | 132 |
|
|
2017
Q2 | $1.34M | Buy |
40,328
+2,295
| +6% | +$76.3K | 0.27% | 68 |
|
|
2017
Q1 | $1.22M | Buy |
38,033
+585
| +2% | +$18.8K | 0.24% | 69 |
|
|
2016
Q4 | $1.36M | Sell |
37,448
-2,855
| -7% | -$103K | 0.28% | 67 |
|
|
2016
Q3 | $1.85M | Buy |
40,303
+320
| +0.8% | +$14.7K | 0.37% | 67 |
|
|
2016
Q2 | $2.01M | Sell |
39,983
-2,977
| -7% | -$150K | 0.41% | 64 |
|
|
2016
Q1 | $2.3M | Sell |
42,960
-545
| -1% | -$29.2K | 0.57% | 57 |
|
|
2015
Q4 | $2.86M | Sell |
43,505
-2,365
| -5% | -$155K | 0.7% | 55 |
|
|
2015
Q3 | $2.59M | Sell |
45,870
-1,380
| -3% | -$77.9K | 0.57% | 60 |
|
|
2015
Q2 | $2.79M | Sell |
47,250
-14,292
| -23% | -$845K | 0.56% | 62 |
|
|
2015
Q1 | $3.83M | Sell |
61,542
-90
| -0.1% | -$5.61K | 0.7% | 58 |
|
|
2014
Q4 | $3.54M | Sell |
61,632
-935
| -1% | -$53.8K | 0.65% | 57 |
|
|
2014
Q3 | $3.36M | Sell |
62,567
-770
| -1% | -$41.4K | 0.63% | 59 |
|
|
2014
Q2 | $3.32M | Sell |
63,337
-193
| -0.3% | -$10.1K | 0.67% | 60 |
|
|
2014
Q1 | $3.36M | Buy |
63,530
+50
| +0.1% | +$2.64K | 0.7% | 56 |
|
|
2013
Q4 | $2.54M | Buy |
+63,480
| New | +$2.54M | 0.54% | 67 |
|